海翔药业 (002099)

Zhejiang Hisoar Pharmaceutical Co.,Ltd.

ASZ

Tags

Weight Loss DrugsDisperse DyesChemical PharmaceuticalsBuyback PlansLow-Profit StocksSME 300 IndexShenzhen ConnectAdvantageous Growth IndexSZSE Medicine Equal Weight IndexPharmaceutical IndexShenzhen A-Share Pharmaceutical IndexCSI All-share Pharmaceutical Sector IndexSZSE 700 IndexSZSE Component Index ReturnYangtze River Delta Economic ZoneHuijin ConceptNEEQSME Board Composite IndexSZSE Selected IndexCS High-end Manufacturing IndexSZSE Pharmaceutical IndexCS Pharmaceutical TI IndexSZSE Component Pharmaceutical IndexSME Board Low Volatility IndexSZSE Component Index Equal WeightZhongchuang Low Volatility IndexZhongchuang 400 IndexCS Innovative Drugs IndexZhejiang

K-Line Chart

No K-line data available

Company NameZhejiang Hisoar Pharmaceutical Co., Ltd.
Listing Date2006-12-26
Issue Price11.56RMB
Registered Capital161871.525310k RMB
Legal RepresentativeXu Guorui
Registered AddressNo. 100 Waisha Branch Road, Jiaojiang District, Taizhou City, Zhejiang Province
IndustryChemical Pharmaceuticals
Main BusinessEngaged in pharmaceuticals and dyes
Company ProfileZhejiang Hisoar Pharmaceutical Co., Ltd. (Abbreviation: Hisoar Pharmaceutical, Stock Code: 002099) is located in Taizhou, Zhejiang. It is a listed company that produces specialty active pharmaceutical ingredients (APIs), formulations, fine chemicals, dyes, and dye intermediates. It is one of the top 100 innovative pharmaceutical industrial enterprises in China, a national Torch Program key high-tech enterprise, one of the first batch of integrity demonstration enterprises in Zhejiang Province, and an excellent self-operated export production enterprise in Zhejiang Province. The company owns Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd., Zhejiang Hisoar Pharmaceutical Sales Co., Ltd., Shanghai Hisoar Pharmaceutical Technology Development Co., Ltd., Taizhou Qianjin Chemical Co., Ltd., Taizhou Quanfeng Pharmaceutical & Chemical Co., Ltd., and Genevida GmbH, among others. The company's main products include APIs for antibiotics, cardiovascular drugs, hypoglycemic drugs, etc., refined chemicals, formulations, dyes, and intermediates. Over 70% of its pharmaceutical products are exported, with its clindamycin series maintaining a leading global production position. The company places great emphasis on EHS and GMP system construction, with dozens of products registered with the US FDA, holding EU CEP (COS) certificates, and passing Japanese GMP certification and domestic GMP certification. Dye products are exported to over thirty countries and regions including Europe, America, and Asia. The 'Ranba' brand reactive dyes are recognized as China Famous Brand Products and National Excellent Torch Program Products.

Stock Details

1. Key Indicators

  • Total Shares(W): 161871.53
  • Circulating A-Shares(W): 161569.79
  • Earnings Per Share(RMB): 0.0000
  • Net Assets Per Share(RMB): 3.1632
  • Operating Revenue(W RMB): 136658.59
  • Total Profit(W RMB): 1858.40
  • Net Profit Attributable to Parent(W RMB): 729.03
  • Net Profit Growth Rate(%): -39.15
  • Weighted Return on Equity(%): 0.1400
  • Operating Cash Flow Per Share(RMB): 0.0110
  • Undistributed Profit Per Share(RMB): 0.2981
  • Capital Reserve Per Share(RMB): 1.8020

2. Main Business

The main business covers:

  • Pharmaceutical Manufacturing
  • Dye Full Industry Chain

3. Company Basic Information

  • Company Name: Zhejiang Hisoar Pharmaceutical Co., Ltd.
  • Listing Date: 2006-12-26
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 100 Waisha Branch Road, Jiaojiang District, Taizhou City, Zhejiang Province, China
  • Website: www.hisoar.com
  • Company Profile：The company was restructured into Zhejiang Hisoar Pharmaceutical Chemical Co., Ltd. with the approval of the Zhejiang Provincial People's Government's Leading Group for Enterprise Listing. It was registered and established on May 13, 2004, at the Zhejiang Provincial Administration for Industry and Commerce, with a registered capital of 80 million yuan. On June 24, 2004, the company was renamed Zhejiang Hisoar Pharmaceutical Co., Ltd.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Zhejiang Donggang Industrial Co., Ltd. General Legal Person 52398.26 32.43
2 Zhejiang Hisoar Pharmaceutical Co., Ltd. - Phase I Employee Stock Ownership Plan Asset Management Plan 2952.37 1.83
3 Shanghai Chengrui Investment Management Co., Ltd. - Chengrui Zhengqian No. 36 Private Securities Investment Fund Private Securities Investment Fund 2700.00 1.67
4 Hong Kong Securities Clearing Company Ltd. Northbound Capital 1093.41 0.68
5 Southern China Securities 1000 Exchange Traded Open-End Index Securities Investment Fund Fund 1035.83 0.64

5. Concept Sectors

  • Biological Vaccine
  • Disperse Dye
  • Hepatitis Concept
  • Innovative Drug
  • Weight Loss Drug
  • Margin Trading & Securities Lending
  • Low-Profit Stock
  • Share Repurchase Plan
  • Consecutive Losses

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information